The S&P 500 (^GSPC) closed at 7,736.52, up 1.79%. The Dow Jones Industrial Average (^DJI) finished at 54,085.88, gaining 1.71%, while the Nasdaq Composite (^IXIC) surged 2.59% to 26,584.99. Small-cap stocks also joined the move, with the Russell 2000 (^RUT) rising 1.85% to 3,036.98. Volatility edged higher, with the VIX (^VIX) up 4.04% to 16.50, while gold pulled back modestly to 4,135.20, down 0.42%. The rally reflected a favorable mix of macro and earnings catalysts. Lower crude prices ($75.25, -.10% over the last 5-days), easing geopolitical concerns, and resilient economic data helped support risk appetite, while investors continued to reward companies tied to artificial intelligence, cloud infrastructure, and semiconductor demand.
AMD Exceeds
A major focus of the session was Advanced Micro Devices (AMD, $518.58, +7%), which reported stronger-than-expected Q2 results after the bell. The chipmaker posted adjusted EPS of $1.66 versus $1.62 expected, on revenue of $11.54 billion versus $11.28 billion expected. Data center revenue remained a key driver, underscoring continued demand for AI-related compute and infrastructure. Even so, the stock reaction suggested investors remain highly selective when it comes to paying for growth.
SPCX Reports For The First Time
Another closely watched report came from SpaceX (SPCX, $125.33, +9.43%, but off 6.28% in the aftermarket), which released its first quarterly results as a public company. Revenue came in at $6.93 billion, with a loss of 26 cents per share. The report reinforced the market’s view that investors are still willing to back long-duration growth stories, but only when the path to scale and profitability looks credible.
The Macro
From a macro perspective, this week’s lineup of economic reports remains important for confirming whether the current rally has real staying power. Investors are watching for additional signals on growth, inflation, and labor-market resilience, all of which will help shape expectations for Federal Reserve policy. If growth remains firm and inflation continues to cool, equities could keep climbing. If not, the recent move may face a tougher test.For now, the message from the market is clear: AI leadership remains intact, earnings matter more than ever, and macro conditions are still supportive enough to keep the bull case alive.
VP Watchlist Updates
Amwell® (NYSE: AMWL)
Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, closed at $10.42, but rose to $11.15, +7.01% in the aftermarket.
Amwell® (NYSE: AMWL) announced (Aug. 4) financial results for the second quarter ended June 30, 2026. Dr. Ido Schoenberg, Chairman and CEO of Amwell stated, “The DHA’s intent to make Amwell a prime contractor is a powerful endorsement of our platform and our people. With subscription revenue now approaching half our total revenue, independently validated behavioral clinical outcomes, no debt, and positive cash flows from operations projected for the fourth quarter this year, we have never been better positioned to lead the era of AI-powered care.”
Amwell Second Quarter 2026 Highlights:
- Recorded Total Revenue of $52.0 million at the top end of the previously provided financial guidance range for Q2
- Achieved subscription revenue of $25.7 million
- Recorded Amwell Medical Group (“AMG”) visit revenue of $24.4 million
- Reported gross margin of 53%
- Net loss was ($9.6) million, compared to ($10.3) million in the first quarter of 2026, continuously moving from quarter to quarter in a favorable trajectory
- Adjusted EBITDA of ($1.2) million compared to ($3.1) million in the first quarter of 2026
- Total visits on the platform were 0.8 million.
Financial Outlook
The Company is significantly improving Adjusted EBITDA, reaffirming its AMG visit guidance, and raising the low end of its 2026 revenue outlook:
- Revenue in the range of $200 million to $205 million increased from $195 million to $205 million
- AMG visits between 1.32 million and 1.37 million
- Adjusted EBITDA in the range between ($9) million to ($7) million increased from ($16) million to ($12) million.
The Company also provided financial guidance for Q3 2026 Revenue and adjusted EBITDA:
- Q3 revenue in the range of $46 million to $48 million
- Q3 adjusted EBITDA expected to in the range of ($5) million to ($3) million.
The Company also reiterated its objective to achieve positive cash flow from operations in the fourth quarter of 2026.
Hudson Pacific Properties (NYSE: HPP)
Hudson Pacific Properties (NYSE: HPP, $13.98) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth industries. Hudson Pacific’s unique and high-barrier tech and media focus leverages a full-service, end-to-end value creation platform forged through deep strategic relationships and niche expertise across identifying, acquiring, transforming and developing properties into world-class amenitized, collaborative and sustainable office and studio space.
HPP will release second quarter financial results before market open on Wednesday, August 5, 2026. The company will hold a conference call to discuss the results at 9:00 a.m. PT / 12:00 p.m. ET the same day. The conference call will be available via live audio webcast on the Investors section of the company’s website at HudsonPacificProperties.com. .
Eupraxia Pharmaceuticals Inc. (EPRX)
Eupraxia Pharmaceuticals Inc. (EPRX, $6.52, +.15%) a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, wrapped up its KOL event today with a clear message for Wall Street and the GI community: EP‑104GI is not just another esophageal steroid, it is being architected to live comfortably inside real‑world upper endoscopy practice for eosinophilic esophagitis (EoE) patients. By the end of the session, the tone had shifted from “could this work?” to “this is how we would use it on Monday,” which is exactly the inflection investors watch for
EPRX announced (July 7) the appointment of Robert Bazemore, Amy Pottand Dr Helen Thackray to the Board of Directors. “We are delighted for Robert, Amy and Helen to join our Board of Directors at a pivotal stage for the company.” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “Their collective expertise across late-stage drug development, commercial strategy, and global product launches will be invaluable as we execute on several key upcoming milestones for EP-104GI and continue to expand our pipeline. Their appointments reflect the commitment of Eupraxia to advancing and expanding our gastroenterology assets in an efficient and effective manner. I also want to thank Paul Geyer and Michael Wilmink for all of the support and contributions they have made to Eupraxia over the last decade as we proved the function and potential of the Diffusphere technology.”
Eupraxia announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”
Modular Medical, Inc. (NASDAQ: MODD)
Modular Medical, Inc. (NASDAQ: MODD, $2.16), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, announced (Aug. 3) plans to initiate the first phase of commercialization of its Pivot tubeless patch pump across five strategically selected U.S. markets beginning in October 2026. The initial rollout will include Atlanta, Cincinnati/Lexington, Dallas, Houston, and Philadelphia, representing a foundational step in the Company’s capital efficient commercialization strategy with its mission to expand access to simplified insulin delivery solutions for all people living with diabetes.
MODD recently (July 22) announced the formation of its Pivot Innovation Council, a cross-functional group of leading clinicians and healthcare experts established to help guide the company’s clinical and commercial strategy. Diabetes care expert Robert Gabbay, MD, PhD, FACP was appointed as chair of the Pivot Innovation Council. The council will provide insights on target patient populations, support optimization of clinical workflows, inform evidence-generation initiatives, and help refine the Pivot product roadmap and go-to-market approach, as the Company continues to scale its differentiated offering.
Modular Medical announced (July 14) announced positive findings from a new comprehensive diabetes patient research initiative further supporting its commercialization strategy. The Company will share these findings and showcase its Pivot™ tubeless insulin patch pump at the upcoming Association of Diabetes Care & Education Specialists (ADCES) Annual Conference in Columbus, Ohio, August 7-10, 2026. Key findings from the assessment of 100 individuals utilizing multiple daily injections revealed significant unmet needs and strong interest in simplified insulin pump technology: 1) 97% of participants stated they would be interested in insulin pump therapy and expressed openness to alternative treatment options, 2) Among the 43% of participants who reported being hospitalized due to hyperglycemia, hypoglycemia, diabetic ketoacidosis (DKA), or hyperosmolar hyperglycemic state (HHS), nearly half reported experiencing such events two or more times annually, & 3) 55% of participants reported finding themselves in environments that were not convenient or private for administering insulin injections at least twice per week, while 31% experienced these situations more than four times per week.
Modular Medical (June 30) announced that the first patients have completed onboarding and training and are now actively using the Pivot™ tubeless insulin patch pump in real-world settings. This milestone marks the transition of the Pivot pump from development into active patient use and represents a significant step in Modular Medical’s commercialization strategy. The Company will now begin collecting real world utilization data and user feedback to support broader adoption and continued product deployment optimization.
MODD announced ( June 26) that the Pivot™ tubeless insulin patch pump is now shipping to physician offices for training. Upon completion of training, these pumps will be presented to potential patients in the next few days and weeks. The Company intends to expand the roster of practices that offer Pivot over the coming months. This is another significant milestone in the deployment of Pivot. Modular Medical looks forward to updating the market when these first patients are using the pump to deliver insulin. The Pivot pump is purpose-built for adults with diabetes on daily injections who have faced cost, complexity, and usability barriers with traditional pump systems. This group represents an estimated 70% of insulin-dependent adults who remain on multiple daily injections, a multi-billion-dollar opportunity within the diabetes technology market.
Similarweb Ltd. (NYSE: SMWB)
Similarweb Ltd. (NYSE: SMWB, $7.42, +1.92%), a leading digital data and analytics company powering critical business decisions, will release second quarter 2026 financial results for the period ended June 30, 2026, before the market opens on Wednesday, August 12, 2026. Management will host a conference call on Wednesday, August 12, 2026, at 8:30 a.m. EDT to discuss the Company’s business and financial results. A live webcast of the call can be accessed from Similarweb’s Investor Relations website at https://ir.similarweb.com.
SMWB announced (June 15) that it has surpassed $300 million in Annual Recurring Revenue (ARR) and signed two multi-year enterprise contracts, each representing seven-figure ARR commitments. Collectively, these contracts represent approximately $47 million in Total Contract Value to be recognized over the next three years and were signed during the second quarter of 2026.
LG Display Co., Ltd. (LPL)
LG Display Co., Ltd. (NYSE: LPL, $3.23, +5.21%) has spent the last few years doing something many hardware companies talk about but few execute well: turning a technology pivot into a full‑blown business transformation that everyday investors can actually follow. Instead of chasing commoditized LCD TV panels in a race to the bottom, LPL is leaning into Gaming OLED, CES‑worthy innovation, and premium automotive displays – and the press trail tells a surprisingly investor‑friendly story.
Yatsen Group (NYSE: YSG)
Yatsen Group (NYSE: YSG, $2.98), a world-class beauty innovation pioneer, announced (July 8) a landmark collaboration to bring its flagship brand, Perfect Diary, to Sephora in China. This partnership integrates Yatsen’s rigorous scientific infrastructure with the world’s leading prestige beauty retailer, marking a significant milestone in Yatsen’s continuing evolution into a global beauty technology powerhouse.
Doximity, Inc. (NYSE:DOCS)
Doximity (NYSE: DOCS, $21.89, +1.06%) is the leading digital platform for U.S. medical professionals. The company’s network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.
Doximity, Inc. will report financial results for its fiscal first quarter ended June 30, 2026 after market close on August 6, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company’s Investor Relations page at https://investors.doximity.com/.
Sable Offshore Corp. (SOC)
Sable Offshore Corp. (SOC, $4.48) is rebooting a controversial but strategically important offshore-pipeline system under federal DPA orders, targeting meaningful production from Platform Hondo while juggling financing needs that could run into the billions and regulatory battles that could reshape California’s energy landscape.
FMC (NYSE:FMC)
FMC Corporation is doing what smart industrial companies often do when the old playbook stops earning its keep: it is pruning, refocusing and leaning harder into the parts of the business that can actually grow. The result is not a victory lap, but it is starting to look like a cleaner, more investable story for FMC Corporation is doing what smart industrial companies often do when the old playbook stops earning its keep: it is pruning, refocusing and leaning harder into the parts of the business that can actually grow. The result is not a victory lap, but it is starting to look like a cleaner, more investable story for FMC [NYSE:FMC, $10.55, +1.83%].
The Sources
[2] How major US stock indexes fared Monday 8/3/2026 https://www.nhregister.com/business/article/how-major-us-stock-indexes-fared-monday-8-3-2026-22372326.php
[3] S&P 500 Rises 1.48% to 7600.50 — Data Talk https://www.morningstar.com/news/dow-jones/2026080310149/sp-500-rises-148-to-760050-data-talk
[4] NASDAQ Composite Rises 2.13% to 25913.90 — Data Talk https://www.morningstar.com/news/dow-jones/2026080310150/nasdaq-composite-rises-213-to-2591390-data-talk
[5] Dow notches record close, S&P 500 and Nasdaq log third … https://www.marketwatch.com/livecoverage/stock-market-today-dow-s-p-500-nasdaq-oil-signs-deescalation-us-iran-war-pmi-palantir
[6] S&P 500 (^GSPC) Historical Data – Yahoo Finance https://finance.yahoo.com/quote/%5EGSPC/history/
[7] Stocks rally near a record as falling oil prices ease Wall … https://www.latimes.com/business/story/2026-08-03/stocks-rally-near-record-as-falling-oil-prices-ease-wall-streets-worries-about-inflation
[8] Falling oil prices help calm worries about inflation, and … https://www.post-gazette.com/business/money/2026/08/03/wall-street-today-august-3-2026/stories/202608030033
[9] Crude Oil – Price – Chart – Historical Data – News https://tradingeconomics.com/commodity/crude-oil
[10] S&P 500 Futures Fall On Higher Yields And Inflation Jitters https://finance.yahoo.com/markets/stocks/articles/us-stock-market-today-p-081539361.html
[11] Stock market next week: Outlook for Aug. 3-7, 2026 https://www.cnbc.com/2026/07/31/stock-market-next-week-outlook-for-aug-3-7-2026.html
[12] Previous reading 53.8. 🔹 ISM Manufacturing PMI – July https://x.com/marketsday/status/2084221739249062018
[13] Wall St Week Ahead Teetering US stock market faces jobs report, big earnings week https://www.reuters.com/business/wall-st-week-ahead-teetering-us-stock-market-faces-jobs-report-big-earnings-week-2026-07-31/
[14] Macroeconomic Outlook Report: Global (Q1 2026 Update) https://www.researchandmarkets.com/reports/6059197/macroeconomic-outlook-report-global-q1-update
[15] Stock Market News for Aug 3, 2026 https://www.theglobeandmail.com/investing/markets/stocks/AMZN/pressreleases/3613535/stock-market-news-for-aug-3-2026/
[16] Microsoft Corp Stock (MSFT) Moved Up by 5.46% on Aug 3: A Full Analysis https://www.tradingkey.com/news/market-movers/262070900-market-movers-msft-20260803
[17] The Capital Breakdown Morning Macro Brief: Monday, August 3, 2026 https://www.moomoo.com/community/feed/the-capital-breakdown-morning-macro-brief-monday-august-3-2026-117031182336005
[18] Here Are Monday’s Top Wall Street Analyst Research Calls: Best Buy, Circle Internet, Corning, Eaton Corporation, eBay, Ingersoll-Rand, NXP Semiconductors, Starbucks, and More https://247wallst.com/investing/2026/08/03/here-are-mondays-top-wall-street-analyst-research-calls-best-buy-circle-internet-corning-eaton-corporation-ebay-ingersoll-rand-nxp-semiconductors-starbucks-and-more/
[19] How major US stock indexes fared Monday 8/3/2026 https://www.yakimaherald.com/news/nation_and_world/business/how-major-us-stock-indexes-fared-monday-8-3-2026/article_b4e06896-8d89-5e90-87c9-c5232c731312.html
[20] Dow Jones Industrial Average | FRED | St. Louis Fed https://fred.stlouisfed.org/graph/?id=DJIA,
[21] S&P 500 futures price on August 3, 2026 – Financial https://robinhood.com/us/en/prediction-markets/financial/events/sp-500-futures-price-on-august-3-2026-aug-03-2026/
[22] Nasdaq leads Dow, S&P 500 higher as Big Tech gains, oil … https://finance.yahoo.com/markets/live/stock-market-today-monday-august-3-dow-sp-500-nasdaq-big-tech-oil-092516872.html
[23] Stock Market Today: Dow Jumps 500 Points; Oil Prices Slide https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-08-03-2026
[24] S&P 500 (DISCONTINUED) (Monthly) – United States https://ycharts.com/indicators/sp_500
[25] S&P 500 Historical Data (SPX) https://www.investing.com/indices/us-spx-500-historical-data
[26] Historic Stock Lookup | Nasdaq, Inc. https://ir.nasdaq.com/stock-information/historic-stock-lookup
[27] How major US stock indexes fared Monday 8/3/2026 https://www.seattlepi.com/business/how-major-us-stock-indexes-fared-monday-8-3-2026-a22372326
Stay Updated with Vista Partners
Subscribe to receive market insights, investing ideas, and the latest updates directly in your inbox.
